Biocon

Biocon Group is a global biopharmaceutical leader with a mission to deliver affordable, high-quality healthcare accessible to millions of people around the world. Guided by its vision, the group is not just driving growth but also shaping a more inclusive and resilient healthcare ecosystem to enable a more equitable world. The company's purpose is to accelerate its reach by bringing transformative therapies to more patients across various geographies and healthcare systems. Its operations are structured across key business areas including Generics, Biosimilars, Research and Manufacturing Services, and Novel Biologics, to serve global healthcare needs. By using advanced science and forming strategic global partnerships, Biocon continues to ensure that life-saving treatments are delivered where they are most needed. In FY25, the company successfully reached over 21 million patients across more than 120 countries through 78 new launches from its biosimilars and generics portfolio.;